Beleave Stock Price To Earning
Beleave fundamentals help investors to digest information that contributes to Beleave's financial success or failures. It also enables traders to predict the movement of Beleave Pink Sheet. The fundamental analysis module provides a way to measure Beleave's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Beleave pink sheet.
Beleave |
Beleave Company Price To Earning Analysis
Beleave's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Beleave Price To Earning | (4.44) X |
Most of Beleave's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Beleave is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, Beleave has a Price To Earning of -4.44 times. This is 117.18% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The price to earning for all United States stocks is 115.46% higher than that of the company.
Beleave Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Beleave's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Beleave could also be used in its relative valuation, which is a method of valuing Beleave by comparing valuation metrics of similar companies.Beleave is currently under evaluation in price to earning category among its peers.
Beleave Fundamentals
Return On Equity | -1.27 | |||
Return On Asset | -0.25 | |||
Operating Margin | (3.87) % | |||
Current Valuation | 5.66 K | |||
Shares Outstanding | 566.37 M | |||
Price To Earning | (4.44) X | |||
Price To Book | 0 X | |||
Price To Sales | 0.0002 X | |||
Revenue | 2.37 M | |||
Gross Profit | 816.46 K | |||
EBITDA | (30.76 M) | |||
Net Income | (33.78 M) | |||
Cash And Equivalents | 120.41 K | |||
Debt To Equity | 2.44 % | |||
Current Ratio | 0.16 X | |||
Book Value Per Share | 0.01 X | |||
Cash Flow From Operations | (9.47 M) | |||
Earnings Per Share | (0.03) X | |||
Beta | 27.8 | |||
Market Capitalization | 566 | |||
Total Asset | 23.61 M | |||
Z Score | -3.3 | |||
Net Asset | 23.61 M |
About Beleave Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Beleave's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beleave using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beleave based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Beleave Pink Sheet
If you are still planning to invest in Beleave check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Beleave's history and understand the potential risks before investing.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |